XSES
BKZ
Market cap5mUSD
Oct 20, Last price
0.12SGD
Name
Suntar Eco-City Ltd
Chart & performance
P/E
60.56
P/S
6.09
EPS
0.01
Vol. 1Y
355.29%
Shs. 5Y
—
Rev. 5Y
6.76%
Div Yld LY
—
Div Yld TTM
—
Revenues
6m
-39.18%
Net income
626k
-92.34%
CFO
-7m
L
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
As an investment holding company, Suntar Eco-City Limited manages diverse operations primarily within the People's Republic of China. Its business activities include supplying health and nutritional products to distributors and engaging in real estate development, selling properties directly to individual buyers. The company's portfolio also encompasses a bottled water enterprise. Established in 2006 and headquartered in Singapore, it was formerly known as Reyphon Agriceutical Limited before rebranding to Suntar Eco-City Limited in June 2012. Suntar Eco-City Limited operates as a subsidiary of Suntar Investment Pte Ltd.
Key people
Pan Shimo
Independent Chairman of the Board, Director · since 2024
Yihong Lan
Executive Director · since 2015
Kok Liang Chew
Joint Company Secretary · since 2020
Pei Pei Lim
Joint Company Secretary · since 2020
Yu Gan Hu
Lead Non-Executive Independent Director · since 2024
Non-Executive Non Independent Director · since 2024
Weiguang Lan
Non- Executive Non-Independent Director · since 2024
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||